FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078610 [Registered on: 26/12/2024] Trial Registered Prospectively
Last Modified On: 24/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Physiotherapy treatment for lateral elbow pain.  
Scientific Title of Study   comparison between blood flow restriction training and mulligan mobilization with movement in the management of lateral epicondylitis 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vidhi Joshi  
Designation  Research scholar 
Affiliation  Amity Institute of Health Allied Sciences 
Address  Department of Physiotherapy, Amity Institute of Health Allied Sciences Amity University F1 LGF Sector 125 Noida UTTAR PRADESH 201313 India

Gautam Buddha Nagar
UTTAR PRADESH
201313
India 
Phone  7599177720  
Fax    
Email  vidhijoshi2115@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjib Kumar Das 
Designation  Associate Professor  
Affiliation  Amity Institute of Health Allied Sciences 
Address  Department of Physiotherapy Amity Institute of Health Allied Sciences Amity University F1 LGF Sector 125 Noida UTTAR PRADESH 201313 India

Gautam Buddha Nagar
UTTAR PRADESH
201313
India 
Phone  8879485847  
Fax    
Email  skdas@amity.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjib Kumar Das 
Designation  Associate Professor  
Affiliation  Amity Institute of Health Allied Sciences 
Address  Department of Physiotherapy Amity Institute of Health Allied Sciences Amity University F1 LGF Sector 125 Noida UTTAR PRADESH 201313 India

Gautam Buddha Nagar
UTTAR PRADESH
201313
India 
Phone  8879485847  
Fax    
Email  skdas@amity.edu  
 
Source of Monetary or Material Support  
Amity Institute of Health Allied Sciences Amity University Noida Uttar Pradesh 
 
Primary Sponsor  
Name  Vidhi Joshi 
Address  Department of Physiotherapy Amity Institute of Health Allied Sciences, Amity University F1 LGF sector 125 Noida Uttar Pradesh 201313 
Type of Sponsor  Other [Self ] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Sanjib Kumar Das  Department of Physiotherapy Amity Institute of Health Allied Sciences, Amity University F1 LGF sector 125 Noida Uttar Pradesh 201313 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vidhi Joshi  Amity Institute of Health Allied Sciences, Amity University  Department of Physiotherapy F1 LGF
Gautam Buddha Nagar
UTTAR PRADESH 
7599177720

vidhijoshi2115@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional NTCC Committee Department of Physiotherapy, Amity Institute of Health Allied Sciences, Amity University, Noida, Uttar PPradesh   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M771||Lateral epicondylitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Blood flow restriction training   Intervention: Participants will perform low-intensity resistance exercises (e.g., wrist extension, wrist flexion, grip exercises) with BFR cuffs applied to the affected arm over the biceps region. The exercises will be performed 3 times per week for 6 weeks. Exercise protocol- Low intensity (20-40% of 1 RM) resistance training with blood flow restriction Wrist flexion-extension Radial and ulnar deviations Grip exercises with ball and hand exerciser BFR cuff application- Load: 20-40% of 1 RM Sets: Two per exercise Rest periods: 30-60 seconds between sets (keep muscle wrapped/occluded during the rest periods for a single exercise, and release wrap for at least 1 minute before beginning a different exercise) Occlusion time: 5-10 minutes total per exercise The pressure of the cuff will be 50 mmgh. Protocol: 30 -15-15-15 reps (30-sec rest break in between will be given each time) Deflate the cuff for 1-minute before the next exercise The sphygmomanometer will be used to apply occlusion to the arm. The groups will also receive conventional therapy including ultrasound therapy, stretching exercises and deep friction massage. 
Comparator Agent  Mulligan mobilization with movement   Mulligan mobilization with movement- Patient position-Supine lying (forearm pronated, elbow extended) Therapist position- walk standing (at the side of mobilizing forearm) The belt will be applied at the forearm near the elbow joint of the patient and around the shoulder of the therapist. The patient will be asked to make a fist and perform the active movement without experiencing any pain while the therapist provides the lateral glide at the forearm using the belt. Mobilization will be provided 3 times a week for 6 weeks Three sets of mobilization with movement of ten repetitions each will be given per session. The groups will also receive conventional therapy including ultrasound therapy, stretching exercises and deep friction massage. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Presence of pain on the lateral epicondyle of the elbow.
2. Tenderness on palpation on the lateral epicondyle.
3. Positive cozens, mills, and maudsley’s test results.
4. Complaints persisting for at least 8 weeks.
5. There is an apparent decline in grip strength in the affected arm.
6. Informed consent form signed by participants. 
 
ExclusionCriteria 
Details  1. Participants who had a history of surgery on the affected arm.
2. Participants with other upper extremity conditions (e.g. Carpal tunnel syndrome, rotator cuff pathology, biceps tear) that could interfere with the assessment of grip strength and function.
3. Participants who had received the corticosteroid injection around the affected elbow within the past 3 months.
4. Participants with systemic conditions, that may affect the healing or muscle performance (e.g. diabetes, rheumatoid arthritis, chronic inflammatory conditions, and hypertension both controlled and
uncontrolled).
5. Participants on blood thinners or anticoagulant therapy, as BFR training could increase the risk of complications.
6. Pregnant women will be excluded due to potential risks associated with BFR training.
7. Participants who will experience significant discomfort, pain, or any other adverse reactions during a trial session of BFR training.
8. Participants with mental or cognitive impairments that could prevent them from understanding the study procedure or following the exercise protocol. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Grip strength measurement, Pain intensity, and functional disability   Baseline, 4th and 6th weeks 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="61"
Sample Size from India="61" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   20/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [vidhijoshi2115@gmail.com].

  6. For how long will this data be available start date provided 30-12-2024 and end date provided 11-05-2025?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
Aims & Objectives –
Aim: To evaluate the relative benefits of blood flow restriction training and mulligan mobilization with movement for alleviating pain, improving grip strength and functional disability in lateral epicondylitis patients.
Objectives- To assess the difference in grip strength between lateral epicondylitis patients receiving blood flow restriction training and those receiving mulligan mobilization with movement.
-To assess the impact of mulligan mobilization with movement and blood flow restriction training on the degree of pain and functional disability in lateral epicondylitis patients and comparison between both.

Hypothesis –
Null hypothesis-Blood flow restriction training and mulligan mobilization with movement will not significantly vary in terms of improving grip strength, reducing pain, or improving functional outcomes in individuals with lateral epicondylitis.
Alternate hypothesis- Blood flow restriction training and mulligan mobilization with movement will differ significantly in terms of improving grip strength, reducing pain, and improving functional outcomes in patients with lateral epicondylitis.

 
Close